Navigation Links
Patient Safety Technologies Reports Second Quarter 2010 Results
Date:8/17/2010

ve of the 14 hospitals named to the U.S. News and World Report 2010-11 Honor Roll.

The company's second quarter financial statements are included in the Quarterly Report on Form 10-Q filed by the company on August 16, 2010 and available at the SEC's website at www.sec.gov  

About Patient Safety Technologies, Inc. and SurgiCount Medical

Patient Safety Technologies, Inc., through its wholly-owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge® System, a solution proven to improve patient safety and reduce healthcare costs by preventing one of the most common errors in surgery, retained foreign objects.  For more information, contact SurgiCount Medical, Inc. at (951) 587-6201 or visit www.surgicountmedical.com.

Safe Harbor Statement

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" (within the meaning of Section 21E of the Securities Exchange Act of 1934) that involve risks and uncertainties. Forward-looking statements reflect our management's current views with respect to future events and financial performance; however, you should not put undue reliance on these statements.  When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions, without limitation, identify forward-looking statements.  Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. These factors and uncertainties include: •our need for additional financing to support our business; the early stage of adoption of our Safety-Sponge® System and the ne
'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015   KaloBios Pharmaceuticals, Inc . ... on developing innovative therapies to benefit patients with diseases ... announced today that the U.S. Food and Drug Administration ... application for KB003, an anti-GM-CSF monoclonal antibody (mAb), in ... IND is now active. The acceptance of ...
(Date:7/29/2015)... , July 29, 2015  The Perinatal ... to improve understanding of the advantages, limitations and ... screening and other diagnostic tests for pregnant women ... DGX ), the world,s leading provider of diagnostic ... support the initiative, through a grant. ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today ... a national broadcast news segment in Australia ... following regulatory and reimbursement approval in that country. ... 1.2 million Australians living with diabetes. As a case in ... great solution for a 13 year old boy with Type ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
... N.C., Nov. 29, 2011 Campbell Alliance, an inVentiv ... specializing in the pharmaceutical and biotech industry, today ... 10 Most Licensable Oncology Projects to Watch.  Selected ... the upcoming Windhover Therapeutic Area Partnerships conference ( ...
... WELLESLEY HILLS, Mass., Nov. 29, 2011  Joseph F. Finn, ... of Epix Pharmaceuticals, Inc. ("Epix") announced today that AMG ... the S1P1 lead compounds will be offered December 8, ... generated by Epix Pharmaceuticals, Inc. and Amgen. ...
Cached Medicine Technology:Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011 2Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011 3AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen. 2
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named ... Health division. In her position, Ramkeesoon will help build and expand work ... Ramkeesoon spent close to a decade at ICF International, most recently as a ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and ... for nearly 38 years, is motivated each and every day by his sincere desire ... shine alongside his many awards and accolades, which include multiple listings in many highly ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today the nonprofit ... Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the ... government, and health care experts can improve patient compliance. , Although influenza, pneumococcal, ...
(Date:7/29/2015)... ... 29, 2015 , ... " Core Organizer ” was featured on NewsWatch as ... applications on the market for iOS, Android, and Windows. Joe Toohey, the host of ... app will help anyone get organized. , Wouldn’t it be great if everyone could ...
(Date:7/29/2015)... ... July 29, 2015 , ... Angelo’s FabriClean, an area rug cleaning company in ... of carpets and rugs. The company will now reverse the damage caused by water ... An overflowing overhead tank, rain leaking through an accidently left open window or a ...
Breaking Medicine News(10 mins):Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Get More Organized with the Core Organizer App 2Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2
... and Palm,Beach will be joined by a third, CyberKnife ... Miami, a world renowned image guided robotic radiosurgery,practice facilitator, ... community-based outpatient cancer treatment facilities. The mission of,MORSE LLC ... number of,patients and physicians. A fourth center is in ...
... AMSTERDAM, The Netherlands, July 14 , - ... Years, Elsevier, a leading publisher of scientific, ... online scientific research,platform, ScienceDirect, has surpassed nine million ... than five years, ScienceDirect is the,largest and most ...
... VICL ) today announced the scheduled presentation ... Phase 1 trial of the company,s,Vaxfectin(R)-formulated H5N1 pandemic ... IBC Life Sciences Next Generation Vaccines conference,(National Harbor, ... of Vaccine Research, Larry R. Smith, Ph.D., will,present ...
... the cooler weather, many young,adults continue to wear slides, ... Brands -- in the locker room, on campus, in,the ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080714/NYFNSP09 ), But, according to ... 30 years in western Wisconsin and member of the ...
... computing solutions provider recognized by one of the most "wired" ... ... Columbus, OH (PRWEB) July 14, 2008 -- Artromick provides accurate ... computing and medical cart equipment. In today's demanding world of ...
... ... life, SAN DIEGO, July 13 ... (NCLR) to unveil a small,tool aimed at battling a big problem -- chronic ... Vida --,Su Guia de Recursos de Salud, with the support of NCLR during ...
Cached Medicine News:Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 2Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 3Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 2Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 3Health News:Choose Flip Flops Carefully for Back to School, Say Chiropractors 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4
ELISA for the detection of Insulin....
... (17alpha-OH-P) is a steroid produced in the ... defined physiological role except as a precursor ... be converted to cortisol by the sequential ... the adrenal glands and ovaries, 17alpha-OH-P can ...
... PC1200 Platelet Incubators bring ... laboratory counter top. These compact ... to have the security of ... without taking up a large ...
The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
Medicine Products: